Address |
75 Park Plaza Boston Massachusetts 02116 United States |
Employees | - |
Website | http://www.paratekpharma.com |
Updated | 07/08/2019 |
Paratek Pharmaceuticals, Inc. engages in the development and commercialization of therapies based upon tetracycline chemistry. Its products include Omadacycline and Sarecycline, which are used for the treatment of serious community-acquired bacterial infections, including community-acquired bacterial pneumonia, acute bacterial skin and skin structure infections, and urinary tract infections. The company was founded in February 2001 and is headquartered in Boston, MA. |